Spinocerebellar ataxia type-12 (SCA12) is a neurological disorder that exhibits a unique progressive tremor/ataxia syndrome induced by triplet (CAG) repeat expansion in 5' UTR of PPP2R2B. SCA12 is one of the most prominent SCA-subtype in India and till date no appropriate disease models have been described. Our aim was to establish human iPSC derived neuronal cell lines of SCA12 and study transcriptomic level alterations induced by CAG expansion. For translational application, peripheral blood transcriptomics of SCA12 patients was also performed. Lymphoblastoid cell lines of three SCA12 patients were reprogrammed to iPSCs and then re-differentiated into pan-neuronal lineage. RNAsequencing based comparative transcriptomics was performed for disease and control cell lineages. Microarray based transcriptomic profiling of peripheral blood of SCA12 patients was performed in a case/control (n=15/9) design. We have successfully created human neuronal cell lines of SCA12 patient as exhibited by their molecular profiling. Differential expression analysis of RNA-Seq data has shown enrichment for type-I interferon signaling and other relevant cellular processes in SCA12-neurons. At the splice-isoform level, we observed an upregulation of expanded CAG containing non-coding transcript of PPP2R2B.
Introduction
SCA12 is an autosomal dominant trinucleotide repeat expansion disorder clinically characterized by cerebro-cerebellar degeneration (i.e. progressive action tremor of hands, gait ataxia, dysarthria, head tremor etc.) and variable onset of other pyramidal and extrapyramidal features during the course of disease progression (Holmes et al., 1999) . The underlying genetic defect in SCA12 is the expansion of CAG repeats (≥43) in 5' region of PPP2R2B (Srivastava et al., 2017) . This gene encodes a regulatory subunit of the heterotrimeric enzyme serine/threonine protein phosphatase 2A (PP2A) which is pivotal to essential cellular functions and role in cancer, neurodegeneration and inflammatory diseases (Janssens and Goris, 2001; Sangodkar et al., 2016) . PPP2R2B transcribes into several repeat containing and non-repeat (non-TNR) containing splice variants that differ at 5' sequence regions and encode protein isoforms with variable N-terminal, thus affecting the localization and substrate specificity of PP2A enzyme (Strack et al., 1998; Dagda et al., 2003) . In earlier reports the role of non -TNR isoform of PPP2R2B has shown to induce apoptotic cell death in cellular models and mitochondrial fragmentation with cristae disruption in fly model of SCA12 (Cheng et al., 2009; Wang et al., 2011) . But the molecular mechanism by which CAG repeat expansion in PPP2R2B induces neurodegeneration is largely unknown. Clinical manifestations of SCA12 include features that are unique to this disease (e.g. action tremor in hands) as well as those overlapping with other cerebello-degenerative disorders (such as gait ataxia and pyramidal features). At the phenotypic level SCA12 is closely connected with other neurodegenerative disorders like Spinocerebellar ataxia type 1-3 & 17, Huntington's disease and Parkinson's disease. Fragile X-associated Tremor/Ataxia Syndrome (FXTAS), which is also considered a phenocopy of SCA12, is caused by TNR expansion of CGG repeats in the 5'UTR of FMR1, resulting into RNA toxicity (Hagerman, 2013; Faruq et al., 2014) . RNA mediated toxicity has been implicated in many TNR diseases caused by repeat expansion either in the coding or non-coding region (Krzyzosiak et al., 2012) . A similar scenario can be anticipated in SCA12 where the CAG repeat expansion in a non-coding region of PPP2R2B. Till date, an appropriate disease model to study the mechanism of CAG expansion mediated SCA12 pathogenesis is lacking. Human-induced-pluripotent-stem cell (HiPSC) offers to be a promising model for elucidating the pathology of several human disorders and their usage gaining momentum owing to its ability to model the disease in patients own genetic background (Sterneckert et al., 2014) . To study the mechanistic role of CAG repeat expansion in SCA12 pathogenesis, here we describe for the first time, the generation of iPSCs from SCA12 patients, followed by the cellular reprogramming of these SCA12-iPSCs into neurons. In order to identify the transcriptional changes induced by the mutation in the disease condition, we have performed whole transcriptome analysis by RNAsequencing in patient iPSC-derived neuronal and other cell lineages and then systematically analyzed the changes in PPP2R2B transcripts level. We have corroborated these observations with insights from the whole blood transcriptomic profile of SCA12 patients so as to understand the aberrant transcriptional milieu in diseased individuals. Our results show enrichment of neurodegeneration pathways in the RNA-Seq data and aberrant expression of PPP2R2B. Surprisingly we find an altered expression of genes related to the interferon signaling pathway in both iPSC-derived neurons and peripheral blood of SCA12 patients.
Materials and methods

Subjects and study approval
Patients were clinically and genetically confirmed for the presence of SCA12 at All India Institute of Medical Sciences (AIIMS) before their recruitment into this study. For iPSC generation, blood samples of three unrelated patients and control were drawn. For genome wide expression study using microarray, peripheral blood was collected from 15 unrelated patients [Male/ Female; 12/3, mean age= 53.6 ± 9.1 years, mean expanded CAG length = 57.8 ± 6.1] and nine controls [Male/ Female; 2/7, mean age= 51.7 ± 5.7 years]. Additionally seven other SCA12 patients [Male/Female; 9/3, mean age= 54.5 ± 9.8 years, mean expanded CAG length = 56.3 ± 6.3] and five controls were included in this study for the validation of RNA-Seq data Supplementary file 1: 
Peripheral blood mononuclear cells (PBMCs) isolation, LCL generation and characterization
PBMCs were isolated from three unrelated symptomatic SCA12 patients and one control using ficoll histopaque (Sigma-Aldrich) gradient following manufacturer's instructions.
PBMCs were then transformed to lymphoblastoid cell lines (LCLs) using Epstein Barr virus (EBV) following a published protocol (Frisan et al., 2001) . LCLs were maintained in RPMI 1640 medium (Life Technologies) supplemented with 20% FBS (Gibco), 2 mM glutamine and 1X Penicillin & Streptomycin (Life Technologies). Direct immunofluorescence was measured to confirm the presence of B cell subpopulation using CD19 cell surface marker.
CD3 staining was also performed to confirm the exclusion of T cells in culture. Cells were washed once with 1 X DPBS, suspended in FACS buffer containing diluted FcR blocking and incubated on ice 10 minutes. Blocking was removed and cells were resuspended in FACS buffer and antibodies labelled with fluorophore (CD19-PerCP-Cy5.5 and CD3-FITC (BD Biosciences) as per manufactures instructions. Cells were then incubated on ice for 30 minutes, washed once with FACS buffer, resuspended in PBS and acquired on FACS Aria (BD Biosciences).
Induced pluripotent stem cells (iPSCs) generation
The generated LCLs of the three patients and one control were reprogrammed via episomal plasmids harboring reprogramming factors as described previously (Okita et al., 2011) .
Briefly 0.2 million LCLs were electroporated with 1µg of three reprogramming plasmids viz., pCXLE-hOCT3/4-shP53-F (Addgene), pCXLE-hSK (Addgene) and pCXLE-hUL (Addgene) using Neon device (Invitrogen). Post electroporation, cells were transferred onto gamma irradiated mouse embryonic fibroblast feeder layer and cultured in iPSC medium containing KnockOut DMEM, 20% KnockOut Serum Replacement, 55 mM beta-mercaptoethanol, 10 mM nonessential amino acids, 2 mM L-glutamine, 1X Penicillin & Streptomycin, 10 ng/ml recombinant human bFGF (PeproTech) supplemented with 50 μ g/ml L-ascorbic acid (Sigma-Aldrich), and 0.5 mM sodium butyrate (Sigma-Aldrich). Reagents were obtained from Life Technologies except stated otherwise. As early as 12-15 days after electroporation, typical human embryonic stem (ES) cells like colonies were observed. Once the colonies grew, they were mechanically passaged onto inactivated mouse embryonic fibroblasts (MEF) feeder layer and propagated in iPSC medium lacking sodium butyrate and ascorbic acid.
Karyotyping was carried out using G banding to check any gross chromosomal abnormalities.
Established iPSC lines were characterized with respect to their pluripotent properties. In-vitro pluripotency assessment was done through embryoid body (EB) formation. For this iPSC colonies were disintegrated (clumps containing 200-300 cell) and transferred into low adherent dishes (Corning) and cultured in EB medium (iPSC medium without basic FGF) till day 4. Then total RNA was isolated from these EBs using RNeasy Mini Kit (Qiagen) and
RNA was converted into cDNA using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Reverse transcriptase PCR was performed for different germ layer markers (ectoderm, endoderm and mesoderm) (Supplementary file 1: Table 2 ). The amplified products were checked on 2% agarose gel using UV trans-illuminator documentation system (Bio Rad).
Neural stem cells (NSCs) generation and neuronal differentiation
Of all the generated cell lines, one of the patient iPSC (IG0002iPSSCA12) and the control iPSC (NC0001iPSCCE) were differentiated towards pan-neuronal lineage using a published protocol (Zhang et al., 2001) with slight modifications. The iPSCs were first converted into embryoid bodies (EBs). After 4-5 days of culture in the neural induction medium (DMEM/F-12 with GlutaMax supplemented with MEM non-essential amino acids (1X), N2 supplement (1X), B27 supplement without vitamin A (2X), basic FGF (20 ng/ml) (PeproTech), EGF (10 ng/ml (PeproTech) Heparin (2μg/ml) (Sigma) and Penicillin-Streptomycin (1X), EBs generated rosette-like structures at their center. The patches of rosettes were marked, manually cut and cultured on laminin-coated dishes in neural expansion medium to obtain a homogeneous population of NSCs. Both patient (IG0002NSCSCA12) and Control (NC0001NSCCE) NSCs were immunostained for neuronal stem cell marker, NESTIN.
NSCs were differentiated into neurons as previously described (Denham and Dottori, 2009; Trujillo et al., 2009 ) with some modifications. Briefly NSCs were plated at a density of 2-3x10 4 cells/cm 2 on Poly-D-lysine/laminin-coated dishes and culture in neural differentiation medium containing neural basal medium supplemented with N2 (1X) and B27 (2X) (with vitamin A) and Penicillin-Streptomycin (1X). On day 7 of differentiation, dibutyryl cAMP (0.5 mM) (Sigma) was added daily for three consecutive days. To obtain mature neurons, cells were grown for 6-7 weeks in the neuronal differentiation medium. Both patient (IG0002NEURONSCA12) and control (NC0001NEURONCE) neurons were characterized for the neuronal markers including TUJ1 (Beta III tubulin) and MAP2 and CAG repeat length of both patient and control's NSCs and Neurons were identified. Reagents were obtained from Life Technologies except stated otherwise.
Immunostaining
Cells were fixed with 4% paraformaldehyde (PFA) for 20 minutes followed by permeabilization with 0.1% Triton-X 100 for 10 minutes. The cells were kept in blocking solution (1% BSA) for one hour at room temperature, incubated overnight at 4°C with diluted primary antibodies. The cells were washed thrice with 1X HBSS (5 minutes per wash) and incubated for 1 hour with diluted secondary antibodies at room temperature. Counter staining for nuclei was done with Hoechst 33342 for 20 minutes at room temperature. Slides were mounted in DABCO and imaging was done using epifluorescence microscope (Nikon Eclipse TE2000-E-PFS, Japan) (Supplementary file 1: Table 3 ).
RNA isolation, cDNA synthesis and quantitative PCR (qPCR)
Total RNA was isolated from cells using RNeasy Mini Kit (Qiagen). To remove any genomic DNA contamination from isolated RNA samples, DNase treatment was given using TURBO DNA-free Kit (Ambion). Additionally to study the expression pattern of PPP2R2B in different brain regions, RNA of different parts of brain (viz. cerebellum, frontal lobe, parietal lobe, medulla oblongata, pons, putamen, substantia nigra) from healthy individuals were procured from CloneTech. cDNA was synthesized from 1μg total RNA using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Primers were designed using an online tool Primer3 (http:// bioinfo.ut.ee/primer3-0.4.0/primer3/) (Supplementary file 1: Table 2 ). qPCR was performed in three technical triplicates on Roche 388 platform (Light Cycler 480 II) using SYBR Green Chemistry (KAPA Biosystems).
Relative gene expression was calculated using published methods (Livak and Schmittgen, 2001; Schmittgen and Livak, 2008) .
RNA sequencing (RNA-Seq)
RNA-Seq libraries were prepared with 1 μ g RNA using TruSeq RNA sample preparation kit.
Cluster generation was carried out on cBot using Illumina SBS kit.v3 protocol. Libraries were sequenced on Illumina HiSeq 2500 (Illumina). Generated bcl files were converted into FASTQ using CASAVA v1.8. Trimming and quality filtering was performed using FASTX tool kit (http://hannonlab.cshl.edu/fastx_toolkit/download.html) and FASTQC (http://www.bioinformatics.babraham.ac.uk/projects/download.html#fastqc). The sequenced reads were further mapped to the reference transcriptome (hg38) using Tophat v2.0.5 allowing a maximum of two mismatches. In order to quantify the gene expression in terms of Fragments Per Kilobase of transcript per Million mapped reads (FPKM) was performed using Cufflinks v2.0.2. FPKM were further used by Cuffdiff v2.0.2 to estimate differential expression of genes (DEG) between patients and controls.
Genome wide expression profiling using microarrays
For genome wide expression analysis using microarray, total RNA was isolated from the peripheral blood of SCA12 patients (n=15) and controls (n=9) using trizol. To reduce the variability, blood collection was done two hours after a light meal for all the subjects and within two hours, RNA extraction procedure was started. For the microarray experiment biotin labelled cRNA samples were generated using TotalPrep RNA amplification kit (Illumina) and hybridized to human WG-6 v3.0 Expression BeadChip array. The Bead Chip was scanned on Illumina iScan System and raw intensity data was extracted without background correction and normalization using GenomeStudio Software Illumina Inc. Probes with detection p-value of 0.05 in at least 3 samples out of 6 in a given array were retained for further analysis. Background correction and quantile normalization was performed using limma package in R. Additionally, we also checked for batch effect using various methods like SNM (supervised normalization method) and ComBat (sva package). To check for the probes (genes) with significant differential expression between control and patients, we have applied t-test/ Wilcoxon test (depending on the distribution). Significant differentially expressed genes between two groups were determined after applying a fold change ≥ 2.0 or ≤ -2 with p value cut off < 0.05.
CAG repeat analysis for detection of expansion mutation
Genomic DNA was extracted from cells using QIAamp DNA Mini Kit (Qiagen). PCR assay was used to amplify CAG repeats region of PPP2R2B using primer sequences (Supplementary file 1: Table 2 ). Fragment analysis was performed on ABI 3730xl Genetic Analyzer and the length of CAG repeats was calculated using GeneMapper (ABI) software after the estimation of the obtained fragment size.
Statistical analysis
For RNA-Seq data analysis, differentially expressed genes (DEGs) with log2 fold change of ≥ 1 or < -1 and p-value of < 0.05, with q-value <0.05 were taken for further analysis. For qPCR, the statistical significance was calculated using Student's t-test. Non-parametric
Mann-Whitney rank sum test was applied in case of non-Gaussian distribution. Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad software).
Availability of data and materials
RNA-Seq data have been deposited in NCBI with accession number SRP110347.
Genome wide expression analysis data for peripheral blood have been deposited with the accession number (GSE101288).
Results
Development of iPSC derived neurons of SCA12
We have generated LCLs from one control (NC0001LCLCE) and three unrelated patients (IG0002LCLSCA12, IG0003LCLSCA12, and IG0004LCLSCA12). Immunophenotyping of these lines showed maximum cell population (87-88%) were positive for B cells markers and negative for T cells in cultured population of cells, indicating their B cell origin. Genotyping showed CAG expansion length remained unchanged in these LCLs. (Fig. 1A-C ). LCLs were then reprogrammed into iPSCs and established lines of both control (NC0001iPSCCE) and patients (IG0002iPSCSCA12, IG0003iPSCSCA12, IG0004iPSCSCA12) were characterized with respect to their pluripotent properties. All the lines showed typical Embryonic stem cells (ES) like morphology in co-culture with inactivated MEF feeder layer cells. iPSCs cultured in standard stem cell medium exhibited blue fluorescence, characteristics of pluripotent stem cells in primed state as reported previously (Muthusamy et al., 2014) . The iPSCs were immunopositive for pluripotency markers (OCT4, SOX2, SSEA4) ( Fig. 2A ) and alkaline phosphatase (data not shown). All lines had shown normal karyotype ( Fig. 2B ) and exhibited in-vitro potential to differentiate into three cellular lineages (ectoderm, mesoderm and endoderm) as evident from their ability to form embryoid body and expressed markers of all the three lineages ( Fig. 2C ). PPP2R2B-CAG length estimation showed no gross genotypic aberrations ( Fig. 2D ). Out of four derived cell lines, one control iPSC (NC0001iPSCCE) and one patient iPSC (IG0002iPSSCA12) were differentiated towards the pan-neuronal lineage.
The iPSCs were first converted into NSCs in neural induction medium and the generated NSCs were confirmed to be nestin positive ( Fig. 3A and Fig. 3B ). NSCs were subsequently differentiated into neurons and characterized using neuronal markers TUJ-1(Beta III tubulin) and MAP2, (Fig. 3C-F) . Both NSCs and neurons exhibited length of the CAG expanded allele was same as it was in PBMCs from which lines were derived (9/16 for control line and CAG 14/60, for patient line) ( Fig. 3G and 3H ). (Fig. 4C) . Validation by qPCR of RNA-Seq data for IRX1, BACE2, DLK1 and RBP1 showed concordance in terms of differential expression ( Fig.   4D ). and calcium ion binding (14/3, up/down genes) terms. Of these enriched 28 term, GO biological term are depicted in Table 1 . Additionally, GSEA of our differential expression data have shown top 10 gene sets and top term was response of interferon signaling pathway and immune system. Axon guidance (10/6, up/down) and NGF signaling pathway (6/13, up/down) were identified among other enriched gene set (Supplementary file 2).
Transcriptomic signatures in SCA12 neurons
Gene ontology (GO) analysis of transcriptome in SCA12 neuron
In addition we also performed GO analysis for DEGs from RNA-Seq data of iPSC and NSC lineage and observed that interferon signaling was enriched only in the neuronal lineage (Supplementary file 1: Table 5 and 6). To find distribution of differentially expressed genes related to interferon signaling, we performed Venn distribution of interferon enriched genes among these generated iPSCs, NSCs and neurons and found overrepresentation in neurons ( Fig. 5A and Supplementary file 1: Table 7 ). In neurons, among induced interferon response, 14 up regulated genes were ISG15, HLA-B, OAS1, OAS3, MX1, IFI27, IFI6, SAMHD1, IFIT1, IFITM1, IFITM3, HLA-C, HLA-E and BST2 while, EGR1, HLA-A were downregulated (Fig. 5B ). We further validated OAS1 and ISG15 in neurons using qPCR and found log 2.8 fold upregulation in expression of ISG15 and log 2.2 fold for OAS1 (Fig. 5C ).
Transcriptomic alteration of genes involved in IFN response and Neurodegeneration
Poly (ADP-ribose) polymerase (PARPs) is a group of stress response family of proteins that have role in diverse functions including DNA damage response and programmed cell death.
We found differential expression of PARP9 and DTXL3. PARP9-DTX3L ubiquitin ligase interact with STAT1and targets host histone to promote interferon-stimulated gene expression which induces degradation of pathogen protease . We further observed upregulation of genes involved in P53 pathway STEAP3, THBS1, CCND2.
GADD45B PERP and CDKN1A. In our study we also observed upregulation of DDX58 and IFIH1 in disease condition. There was also an overlap of altered genes with genes related to neurodegenerative diseases, including Alzheimer's disease (AD) (hsa05010), Parkinson's disease (PD) (hsa05012), (hsa05014), Huntington's disease (HD) (hsa05016) and Prion disease (hsa05020) (Supplementary file 1: Table. 8).
Similarities of SCA12 DEGs with expression alteration in other cerebellar ataxias models
In SCA12 fly model, increase activity of pro-apoptotic genes and severe mitochondrial fragmentation has been reported (Wang et al., 2011) . We observed differential expression of group of genes related to differential activities of mitochondrial functions. These were (1) dysregulation of NDUFV2, NDUFS5 and ATP5C1 genes related to mitochondrial electron transport chain and ATP synthesis (2) upregulation of apoptotic genes DFFA, PRKAR1B CASP7 (3) upregulation of antioxidant genes such as CYBA and SEPP1 among DEGs. The expression of SOD2 was observed to be induced (2 fold) but was not within statistical q value <0.05 limit (4) Upregulation of PPARGC1A (PGC1α), a crucial component of mitochondrial bioenergetics was also observed.
Calcium signaling has been implicated in pathophysiology of spinocerebellar ataxias (Guergueltcheva et al., 2012; Kasumu and Bezprozvanny, 2012) . We observed upregulation of PRKCB, PLCB1, DRD1, GRM1, ADCY9 and downregulation of PRKCA and EGFR in diseased stage. Similarly glutamate signaling has been observed to be disrupted in various cerebellar ataxia model system and our results also revealed upregulation of GRID1 and downregulation of GRIK5, GRIK2 and GRIA3 genes. Down regulation of an insulin-like growth-factor binding protein (IGFBP5) has been reported in SCA1 and SCA7 transgenic mice (Gatchel et al., 2008) . We observed upregulated IGFBP5 in SCA12 neurons.
Another gene ontology open source tools Enrichr (Kuleshov et al., 2016) also revealed enrichment of GO biological process related to immune responses (Supplementary file 1: (Wang et al., 2011) . From RNA-Seq analysis, we observed a differential expression of PPP2R2B splice isoforms across three lineage of SCA12 patients and control cells (Fig. 6A ).
V3 (CAG coding transcript) was observed to be the most abundant transcript across all the lineages of controls and iPSC and neuronal lineages of disease lines. In control-iPSC, V3 was the only transcript with FPKM >1, in control-NSC expression of other CAG containing transcript (RNA26203 and V10) were observed next to V3, whereas, in control-neurons expression of V2 was second highest after V3. In disease-iPSCs an increase in expression of RNA26203 was noted (>1 FPKM) (Supplementary file 1: Table. 10). In disease-neurons the abundant transcript observed was RNA26203 followed by V2 and V3. In disease-neurons, a slight upregulation of RNA26203 (log2FC 0.78, p-value 0.08) transcript was observed whereas V3 transcripts (log2FC -1.78, p-value 5x10 -5 ) and V2 (log2FC -0.76, p-value 0.0077) were found downregulated. The expression pattern of PPP2R2B isoforms was validated by qPCR and in comparison to control cell lineages, disease lines shown downregulation of V2, V3, V4, V10 and V11, whereas RNA26203/V12 transcript was observed to be upregulated in iPSCs (log2FC 3.5), NSCs (log2FC 4.7) and abundant expression (log2FC 6.07) in disease neurons (Fig. 6B) . As RNA-Seq data have not shown any upregulation of RNA26203 in NSCs which was observed through qPCR in disease-NSCs, which prompted us to speculate whether primers (for qPCR) designed for V12 transcript (primers flanked the CAG region) captured any novel isoform, as the expression of V12 was also observed to be highly upregulated in disease neurons. qPCR product, on 2% agarose gel, showed the presence of expanded allelic copy (RNA) along with normal allele (data not shown).
To further investigate regarding the occurrence of any other isoform of PPP2R2B, we additionally aligned RNA-Seq reads for each sample (patient and control lines) for the region around the CAG repeat (chr5: 146, 877, 879, 594) and in the regions near PPP2R2B
promoter. In this region, we plotted the read density and found that control cell lines from each stage i.e. iPSC, NSC and Neuron contained only a small number of reads upstream of CAG repeat. However, among both the replicates of neuron cells from the disease condition, a uniformly distributed read density could be seen upstream of CAG repeat. This pattern of sequencing read distribution was also observed in NSC stage but not in iPSC. Occurrence of these additional sequencing reads upstream region suggests a possible existence of some novel isoform with respect to PPP2R2B in the disease condition ( Fig. 6C-E ). Further to explore the expression pattern of PPP2R2B in SCA12-neurons, we also quantified PPP2R2B transcriptional changes in peripheral blood of patients and controls (n=5 each). Compared to controls, all repeat containing isoform had lower expression in blood similar to iPSC derived neurons. Among the various isoforms studied, the expression of isoforms V2 and V4 were not detectable in the blood samples of both controls and patients (Fig. 6 F-I) and no heightened expression of V12 was observed.
Region specific expression of PPP2R2B in healthy brain
Initially we compared PPP2R2B expression of the cell lines generated and healthy control brain tissues. The expression of all the isoforms of PPP2R2B, was found in healthy control derived neurons similar to healthy brain tissues. To study the regional expression of PPP2R2B in brain, we also assessed the expression pattern of PPP2R2B splice isoforms in different brain regions of healthy individuals' viz. cerebellum, frontal lobe, parietal lobe, medulla oblongata, pons, putamen, substantia nigra (Fig. 6J ). We observed that PPP2R2B isoforms were variably expressed across the brain regions and V3 being the highest in expressed in all the regions. The expressions of non-coding CAG containing transcripts was higher in putamen for V11 and cerebellum and parietal lobe for V12.
Genome-wide transcriptional profiling of peripheral blood of SCA12 patients
Genome wide gene expression analysis of blood transcriptomics identified 11 DEGs (3 upregulated and 8 down regulated) (Supplementary file 1: Table 11 ). CCL23 and LGALS2
were upregulated and among the downregulated set of genes, CYP261, GPR97, HEY1, LIMK2, PI3, SLP1 were the important candidates with a possible role in neurodegeneration.
Profiling of inflammatory signature in peripheral blood of SCA12 patients
Further to explore interferon signature in peripheral blood of SCA12 patients, we quantified the expression of several genes associated with inflammatory response in peripheral blood of representative SCA12 and controls (n=5). We found significant up regulation of IFI6 in patients blood compared to controls (Fig. 7A-F ).
Discussion
Modelling SCA12 using patient-specific iPSCs
Radiologically and neuropathologically, SCA12 brain shows pattern of degeneration restricted to cerebral and cerebellar cortex (Holmes et al., 1999; O'Hearn et al., 2015; Srivastava et al., 2017 ). An iPSC-derived neuronal lineage might serve as an alternate surrogate experiment material to study the molecular events in SCA12. In our study we were able to generate iPSCs of SCA12 patients noninvasively from LCLs to further differentiate into neuronal lineage. The generated neurons displayed characteristics of a pan-neuronal lineage. We did not expect morphological differences in these SCA12 neurons at early stages as like other neurodegenerative disease SCA12 produces a late onset phenotype and even neuropathological studies have not shown any morphological differences in the disease affected brain areas except for neuronal loss and gliotic changes (O'Hearn et al., 2015) .
We however used these derived neurons at early stage for an in-depth characterization at the transcripts level in disease condition of SCA12 and studied the whole transcriptomics and transcription of PPP2R2B alternate splice isoforms.
Signatures of inflammation in both SCA12 derived neuronal lineages and peripheral blood
In our SCA12-neuronal cells, of interests, we observed an induced response of type-I interferon signaling pathway genes (IFI27, IFI6, OAS1, OAS3, MX1 and others). Interferons are a large group of structurally related cytokines play protective defenses against viral infection (Sadler and Williams, 2008) . Apart from interference with viral proliferation in a typical scenario induction of interferons can also been observed in the absence of pathogens.
IFN activation also play as inflammatory mediators in neurodegeneration in Alzheimer's disease, Huntington disease and Friedreich Ataxia (FRDA) (Taylor et al., 2014; Miller et al., 2016; Sanchez et al., 2016) . Interferon inducible inflammatory responses is frequently linked to interferon-induced apoptosis and DNA damage pathway (Brzostek-Racine et al., 2011) . In the present study upregulation of genes involved in DNA damage (PARP9 and DTXL3) and
interferon-induced apoptosis (OAS1 and OAS3) were observed and it is consistent with findings reported in FRDA and other neurodegenerative diseases (Nakad and Schumacher, 2016; Sanchez et al., 2016) . Stimulation of several interferon induced genes (IFN) such as
OAS1and 3, ISG15, MX1 activate latent RNase L, which degrades viral and endogenous RNA and induces transcription of genes related to interferon signaling Schneider et al., 2014) .
Another gene related to IFN response, DDX58 and IFIH1 were found upregulated and of which DDX58 encode an RIG-I-like receptor dsRNA that recognized viral double stranded RNA (Yoneyama et al., 2004) . It initiates immune response through mitochondrial antiviral signaling and shown to be associated with neuroinflammation (de Rivero Vaccari et al., 2014; MacNair et al., 2016) . Upregulation of DDX58 and IFIH1 in SCA12 suggest that mechanism of neurodegeneration could be a consequence of inflammation that is activated through the RIG1 signaling in response to over expression of RNA.
From peripheral blood transcriptomics data we were able to see an alteration in expression of genes related to immune response. The significantly expressed genes in blood transcriptome of SCA12 belonged to innate immunity. Among these, CCL23 is a member of the CC chemokine subfamily and GPR97 belongs to adhesion G-protein coupled receptor family reported as biomarker in inflammatory diseases (Pawlak et al., 2014) . Similarly, LIMK2 is a member of PDZ/LIM family which has role in physiological functioning of nervous system pro-survival induced by DNA damage pathway and genotoxic stress (Cuberos et al., 2015) .
Among other DEGs, PI3 and SLP1 are related to innate immune response and their synergistic functions play an antimicrobial role (Sallenave, 2010) . Another candidate of interest, IFI6 belong to family of interferon inducible factor and play role in interferon signaling pathway. Its encoded protein play role in antiviral activity and regulation of apoptosis (Meyer et al., 2015; Qi et al., 2015) . Upregulation of IFI6 in peripheral blood similar to RNA-Seq findings further supports the involvement of immune mechanism in pathogenesis of SCA12. Inflammation linked to antiviral immune response through RNA triggers is implicated in pathogenesis of diseases (Olejniczak et al., 2015) . The secondary structure of expanded RNA and mutant transcripts, products of bidirectional transcription, alternatively spliced transcripts, and RNAs released from necrotic cells are recognized by pathogen-associated molecular patterns receptors and cellular sensors (PKR, OAS, RIG-I, MDA5 and Toll-like receptors) (Tian et al., 2000; Bañez-Coronel et al., 2012; Nalavade et al., 2013; Richards et al., 2013) . This may activate several interferon induced genes OAS family resulting into transcription of inflammatory genes. Though, at this point we are not able to show the formation of these RNA secondary structures in SCA12-neurons or other lineages but RNA mediated inflammatory mechanism is speculative in SCA12 (Nalavade et al., 2013; Olejniczak et al., 2015) . Our whole transcriptomic studies on SCA12-neuron suggested an induced response to IFN signaling and possible indicating and RNA driven mechanism of these inflammatory signals. The observation of a highly upregulated noncoding CAG containing V12/RNA26203 or yet unidentified novel isoform of PPP2R2B in our study supports this possibility, while all other transcript isoforms of PPP2R2B were found downregulated.
Recapitulation of gene expression signatures of other neurodegenerative diseases in SCA12 iPSC-derived neurons
In addition to inflammatory response, our study has observed dysregulation of key pathways implicated in neurodegeneration and other related cellular processes. We observed aberrant expression of genes related to mitochondrial bioenergetics, NADPH (Nicotinamide adenine dinucleotide phosphate) and cytochrome oxidase complex components, apoptosis and antioxidant. This corroborates with the observation in SCA12 fly model (Bβ2 twins/tws overexpression model) wherein mitochondrial fragmentation with cristae disruption were observed in photoreceptor neurons of SCA12 fly, accompanied with increase in reactive oxygen species (ROS) production, cytochrome c, and caspase 3 activity leading to apoptosis and decreased life span of fly (Dagda et al., 2008; Wang et al., 2011) . We also observed an upregulation PPARGC1A (PGC1α), a crucial component of mitochondrial bioenergetics similar to as reported in Parkinson disease (Zheng et al., 2010) . Notably, the calcium and glutamate signaling has been observed to be disrupted in various cerebellar ataxia model system. In the present study we also identified several differentially genes belonging to such important pathways. Dysregulation of insulin-like growth-factor pathway has reported in SCA1 and SCA7 (Gatchel et al., 2008) and we observed an upregulation of IGBP5 in SCA12 neurons. Of interest, among pathways of other neurodegenerative disorders, we observed some overlap of DEGs with genes reported in Alzheimer disease (BACE2), and mitochondrial genes NDUFV2 and NDUFS5 common to AD, PD and HD pathways (Supplementary file 1: Table 8 ). This suggests a common link of neurodegeneration through our SCA12-neuronal cells.
In the existing literature it has been reported that PPP2R2B is brain specific in expression PPP2R2B gene encodes a regulatory subunit of PP2A, known to be involved in several interrelated signaling pathways (Janssens and Goris, 2001; Dagda et al., 2003; Sangodkar et al., 2016) . The aberrant expression of PPP2R2B may affects PP2A activity functioning which in turn dysregulate various signaling cascade as we have observed an overall downregulation of PPP2R2B might result in a loss of function. RNA mediated toxicity has been implicated in many TNR diseases caused by repeat expansion either in the coding or non-coding region (Krzyzosiak et al., 2012) . A similar scenario can be anticipated in SCA12 where the CAG repeat expansion in a non-coding (untranslated) region of PPP2R2B. In SCA12 it has been shown that the length of the CAG repeats alters the expression of the PPP2R2B (Lin et al., 2010; O'Hearn et al., 2015) . Overexpression of CAG repeat containing isoform of a noncoding RNA in SCA12 is reminiscent of the expression pattern observed in FXTAS (Hagerman, 2013) and may exert cytotoxic effects through various mechanisms such as RAN translation, antisense and poly-serine mediated pathophysiology (Zu et al., 2011; Nalavade et al., 2013) . Elongated CAG repeat motifs in their UTRs form secondary structures which can sequester different important proteins, leading to the formation of RNA foci and subsequently causing cell death. Ubiquitin positive inclusion bodies in the substantia nigra have also been observed in SCA12 (O'Hearn et al., 2015) . Hence, there might exist overlaps in the disease mechanism between SCA12 and FXTAS.
Conclusions
In SCA12-neuronal cells, we have observed a heightened expression of CAG expanded RNA transcript in neuronal lineages. The identified signatures of inflammation in the peripheral blood tissue and patient iPSC-derived neurons open the possibilities of monitoring the progression and prognosis of disease. This may be helpful to identify anti-inflammatory molecules that can be effective as a therapeutic approach or for slowing the progression of disease. To our knowledge, this is the first study to address SCA12 pathogenesis using patient derived iPSC/neuronal cells and. and generates transcriptomic data resources for future studies. Trinucleotide repeat
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